Anavex Life Sciences (AVXL) Times Interest Earned (2016 - 2025)
Anavex Life Sciences (AVXL) reported Times Interest Earned of -$0.0 for Q4 2025, up 98.87% on a YoY basis from -$0.0 in Q4 2024, and down 713.44% sequentially from -$0.0 in Q3 2025.
Anavex Life Sciences (AVXL) Times Interest Earned (2016 - 2025) Analysis & Trends
Anavex Life Sciences (AVXL) has 10 years of Times Interest Earned data on file, last reported at -$0.0 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 98.87% year-over-year to -$0.0; the trailing twelve-month figure through Dec 2025 stood at -$0.02 (up 97.86% YoY), and the FY2025 full-year result was -$0.0, up 99.77% from the prior year.
- Times Interest Earned eased to -$0.0 in Q4 2025, from -$0.0 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.95 in Q2 2021 to a low of -$1.95 in Q2 2024.
- A 5-year average of -$0.18 and a median of -$0.23 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 255.06% in 2021 and slumped 464.32% in 2024, its largest moves.
- Tracing AVXL's Times Interest Earned over 5 years: stood at -$0.09 in 2021, then plunged by 241.81% to -$0.3 in 2022, then climbed by 21.38% to -$0.24 in 2023, then gained by 17.59% to -$0.2 in 2024, then jumped by 98.87% to -$0.0 in 2025.
- Business Quant data shows AVXL's Times Interest Earned at -$0.0 in Q4 2025, -$0.0 in Q3 2025, and -$0.32 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.32 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -1.95 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.25 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.14 |
| Dec 31, 2021 | -0.09 |
| Sep 30, 2021 | 0.92 |
| Jun 30, 2021 | 0.95 |
| Mar 31, 2021 | 0.93 |